Comments
Sun Pharma's shares fell nearly 2 per cent on Tuesday. The USFDA on Friday issued Form 483 with 11 observations after inspection of the company's Dadra facility during March 22-29.
An FDA Form 483 is issued to a firm's management at the conclusion of an inspection, when an investigator(s) has observed any conditions that in their judgement may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
The company says it has submitted its response to the USFDA within the stipulated timeline.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.